NEW YORK, Nov. 15, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST).

If you would like to discuss our investigation, please contact us via email [email protected] or by calling (212) 687-1980.

On November 15, 2022, prior to market open, Scorpion Capital released an investigative report on Twist titled, “Twist Bioscience (Nasdaq: TWST) A Cash-Burning Inferno That Is Not A Going Concern, Operating A Ponzi-Like Scheme That Will End In Bankruptcy . Just another “synthetic biology” scam, this time with an absurd “silicon DNA chip” and financial data so bogus it could be criminal. Price target: $0.”

On November 15, 2022, Twist shares opened at $28.76 per share, down $9.24 per share from the November 14, 2022 close of $38 per share, down over 24%, while very high Volume.

This press release may be considered an attorney’s advertisement in some jurisdictions under applicable laws and ethics rules.

WHY CONTACT KAPLAN FOX – Kaplan Fox is a leading national law firm focused on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of securities disputes experience, Kaplan Fox provides the professional experience and track record that clients demand. By prosecuting cases at the federal and state levels, Kaplan Fox has successfully shaped the law by winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, please visit our website at www.kaplanfox.com.

If you have any questions about this study, please contact:

Jeffrey P Campisi
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th floor
New York, New York 10022
(212) 687-1980
E-mail: [email protected]

Laurence D. Konig
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560…